Results 1 to 10 of about 100,001,731 (203)

Bilateral basal ganglia ischemia associated with COVID-19: a case report and review of the literature

Journal of Medical Case Reports, 2021
Background Coronavirus disease 2019, caused by the severe acute respiratory syndrome coronavirus 2, has a broad clinical spectrum, from asymptomatic to multi-organ dysfunction.
Khurram Khaliq Bhinder, Ahsun Rizwan Siddiqi, Muhammad Junaid Tahir, Hamza Maqsood, Irfan Ullah, Zohaib Yousaf   +5 more
doaj   +1 more source

Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report

Journal of Medical Case Reports, 2021
Background The topic of natural immunity related to severe acute respiratory syndrome coronavirus 2 remains controversial. Although evidence suggests postinfection immunity can be achieved, there have been reported cases of reinfection with similar or ...
Nimrah Bader, Mahmood Khattab, Fahmi Farah   +2 more
doaj   +1 more source

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz, Davide Capodanno, Gilles Montalescot, Dominick J. Angiolillo   +3 more
doaj   +1 more source

Undocumented Migrants Reintroducing COVID-19, Yunnan Province, China

Emerging Infectious Diseases, 2021
To limit the spread of severe acute respiratory syndrome coronavirus 2, the government of China has been monitoring infected travelers and minimizing cold-chain contamination. However, other factors might contribute to recurring outbreaks. We analyze the
Meiling Zhang, Jienan Zhou, Senquan Jia, Xiaonan Zhao, Yaoyao Chen, Yanhong Sun, Zhaosheng Liu, Xiaofang Zhou, Duo Li, Chunrui Luo, Yong Zhang, Violet Magoma Onsongo, Yong Shao, Xiaoqing Fu   +13 more
doaj   +1 more source

Symptomatic severe acute respiratory syndrome coronavirus 2 reinfection in a lupus patient treated with hydroxychloroquine: a case report

Journal of Medical Case Reports, 2021
Background Hydroxychloroquine and chloroquine have been used for hospitalized coronavirus disease 2019 patients because of their antiviral and anti-inflammatory function.
Astrid Muyldermans, Piet Maes, Tony Wawina-Bokalanga, Tine Anthierens, Olivier Goldberg, Magali Bartiaux, Oriane Soetens, Ingrid Wybo, Sigi Van den Wijngaert, Denis Piérard   +9 more
doaj   +1 more source

SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020–2021

Emerging Infectious Diseases, 2021
We determined incidence of severe acute respiratory syndrome coronavirus 2 and influenza virus infections among pregnant and postpartum women and their infants in Kenya during 2020–2021.
Nancy A. Otieno, Eduardo Azziz-Baumgartner, Bryan O. Nyawanda, Eunice Oreri, Sascha Ellington, Clayton Onyango, Gideon O. Emukule   +6 more
doaj   +1 more source

Distinct characteristics on mixed infection of SARS-CoV-2 variants and other respiratory pathogens among patients with acute COVID-19 in central China

Frontiers in Cellular and Infection Microbiology
BackgroundReports on mixed infection with different severe acute respiratory syndrome coronavirus 2 variants and other respiratory pathogens in patients with acute coronavirus disease in China remain scarce.
Yiman Geng, Youhua Yuan, Xuhong Lin, Jingjing Wei, Qi Zhang, Xiaohuan Mao, Xiaohuan Zhang, Xiulei Zhang, Yuan Zhang, Jing Zhao, Fengxia Guo, Peiming Zheng   +11 more
doaj   +1 more source

Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions

Emerging Infectious Diseases, 2020
We aerosolized severe acute respiratory syndrome coronavirus 2 and determined that its dynamic aerosol efficiency surpassed those of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome. Although we performed experiment only
Alyssa C. Fears, William B. Klimstra, Paul Duprex, Amy Hartman, Scott C. Weaver, Kenneth S. Plante, Divya Mirchandani, Jessica Ann Plante, Patricia V. Aguilar, Diana Fernández, Aysegul Nalca, Aysegul Totura, David Dyer, Brian Kearney, Matthew Lackemeyer, J. Kyle Bohannon, Reed Johnson, Robert F. Garry, Doug S. Reed, Chad J. Roy   +19 more
doaj   +1 more source

Immune characteristics of human immunodeficiency virus/severe acute respiratory syndrome coronavirus 2 coinfection: A case report and mini-review

SAGE Open Medical Case Reports, 2021
Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 has rapidly spread throughout the world and has become a global pandemic.
Aimei Liu, Jie Wei, Yuanlong Xu, Dayong Huang, Kangyan Lv, Zhihao Meng, Junli Huang, Liling Huang, Guowei Wu   +8 more
doaj   +1 more source

Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab

Multiple Sclerosis Journal - Experimental, Translational and Clinical, 2023
The immunomodulatory effects of disease-modifying therapies for multiple sclerosis might affect the immune response to vaccines for severe acute respiratory syndrome coronavirus 2.
Mark Gudesblatt, Myassar Zarif, Barbara Bumstead, Marijean Buhse, Olivia Kaczmarek, Hanyue Li, Zhaonan Sun, Nicole Scott, Jason P Mendoza, Robin L Avila   +9 more
doaj   +1 more source